Christopher M. Lindblom
Nessuna posizione attualmente
Storia della carriera di Christopher M. Lindblom
Precedenti posizioni note di Christopher M. Lindblom
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 25/04/2016 | 25/07/2016 |
| Treasurer | 25/07/2016 | 01/10/2016 | |
| DNIB UNWIND INC | Direttore Amministrativo | 01/03/2014 | 21/03/2016 |
| Direttore Finanziario/CFO | 01/03/2014 | 21/03/2016 | |
| Segretario Aziendale | 01/03/2014 | 21/03/2016 | |
| Treasurer | 01/03/2014 | 21/03/2016 | |
| INFINITY PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/01/2006 | 12/04/2013 |
| Corporate Officer/Principal | 12/04/2013 | - | |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Direttore Finanziario/CFO | 07/06/2013 | 07/06/2013 |
| Corporate Officer/Principal | 07/06/2013 | 19/06/2013 | |
| Treasurer | 19/06/2013 | - |
Formazione di Christopher M. Lindblom
| Boston College | Masters Business Admin |
| Syracuse University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Treasurer | 3 |
| Comptroller/Controller/Auditor | 2 |
| Corporate Officer/Principal | 2 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
